Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Llythyr › adolygiad gan gymheiriaid

StandardStandard

Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply. / Hughes, Dyfrig ; Culeddu, Giovanna ; Plumpton, Catrin et al.
Yn: Ophthalmology, Cyfrol 126, Rhif 3, 03.2019, t. e24-e25.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Llythyr › adolygiad gan gymheiriaid

HarvardHarvard

Hughes, D , Culeddu, G , Plumpton, C , Wood, E, Dick, AD, Beresford, MW & Ramanan, AV 2019, 'Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply.', Ophthalmology, cyfrol. 126, rhif 3, tt. e24-e25. https://doi.org/10.1016/j.ophtha.2018.12.005

APA

Hughes, D., Culeddu, G., Plumpton, C., Wood, E., Dick, A. D., Beresford, M. W., & Ramanan, A. V. (2019). Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply. Ophthalmology, 126(3), e24-e25. https://doi.org/10.1016/j.ophtha.2018.12.005

CBE

Hughes D , Culeddu G , Plumpton C , Wood E, Dick AD, Beresford MW, Ramanan AV. 2019. Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply. Ophthalmology. 126(3):e24-e25. https://doi.org/10.1016/j.ophtha.2018.12.005

MLA

Hughes, Dyfrig et al. "Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply.". Ophthalmology. 2019, 126(3). e24-e25. https://doi.org/10.1016/j.ophtha.2018.12.005

VancouverVancouver

Hughes D , Culeddu G , Plumpton C , Wood E, Dick AD, Beresford MW et al. Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply. Ophthalmology. 2019 Maw;126(3):e24-e25. Epub 2019 Chw 22. doi: 10.1016/j.ophtha.2018.12.005

Author

Hughes, Dyfrig ; Culeddu, Giovanna ; Plumpton, Catrin et al. / Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply. Yn: Ophthalmology. 2019 ; Cyfrol 126, Rhif 3. tt. e24-e25.

RIS

TY - JOUR

T1 - Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with Juvenile Idiopathic Arthritis: Authors’ reply.

AU - Hughes, Dyfrig

AU - Culeddu, Giovanna

AU - Plumpton, Catrin

AU - Wood, Eifiona

AU - Dick, Andrew D.

AU - Beresford, Michael W.

AU - Ramanan, Athimalaipet V.

PY - 2019/3

Y1 - 2019/3

U2 - 10.1016/j.ophtha.2018.12.005

DO - 10.1016/j.ophtha.2018.12.005

M3 - Letter

VL - 126

SP - e24-e25

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 3

ER -